kneat.com, inc., (KSI) Fair Value & Analysis
Healthcare · CA · Market cap C$521M
Fair value as of: Jun 24, 2026
Analysis
kneat.com, inc., (KSI) currently trades at C$6.45, while our model-based Fair Value estimate is C$1.76 — implying the stock looks roughly 72.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. It also provides professional services, including consulting, training, process mapping, project management, and other services. kneat.com, inc. was founded in 2007 and is based in Limerick, Ireland.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is kneat.com, inc., (KSI) undervalued?
What is the fair value of KSI?
What is the quality score of KSI?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.